| Mar'20 | Dec'19 | Sep'19 | Jun'19 | Mar'19 | Dec'18 | Sep'18 | Jun'18 | Dec'17 |
|---|---|---|---|---|---|---|---|---|
Assets | ||||||||
Current assets: | ||||||||
Cash and cash equivalents | ||||||||
257,695 | 187,043 | 206,362 | 90,348 | 108,476 | 126,302 | 138,577 | 155,015 | 5,963 |
Prepaid expenses and other current assets | ||||||||
7,652 | 8,658 | 7,345 | 7,840 | 5,203 | 3,718 | 1,501 | 1,132 | 345 |
Total current assets | ||||||||
265,347 | 195,701 | 213,707 | 98,188 | 113,679 | 130,020 | 140,078 | 156,147 | 6,308 |
Property and equipment, net | ||||||||
3,407 | 3,696 | 2,673 | 2,741 | 2,864 | 2,634 | 2,306 | 2,050 | 349 |
Other assets | ||||||||
974 | 1,117 | 825 | 1,060 | 825 | 825 | 888 | 533 | 365 |
Total assets | ||||||||
269,728 | 200,514 | 217,205 | 101,989 | 117,368 | 133,479 | 143,272 | 158,730 | 7,022 |
Liabilities and stockholders’ equity | ||||||||
Current liabilities: | ||||||||
Accounts payable | ||||||||
2,135 | 3,949 | 1,408 | 2,572 | 3,458 | 2,784 | 1,582 | 4,193 | 527 |
Accrued expenses and other current liabilities | ||||||||
10,638 | 10,068 | 8,502 | 6,193 | 6,477 | 7,822 | 3,845 | 5,438 | 2,098 |
Total current liabilities | ||||||||
12,773 | 14,017 | 9,910 | 8,765 | 9,935 | 10,606 | 5,427 | 9,631 | 2,625 |
Warrant to purchase redeemable convertible preferred stock | ||||||||
- | - | - | - | - | - | - | - | 35 |
Derivative liability | ||||||||
- | - | - | - | - | - | - | - | 371 |
Deferred rent, net of current portion | ||||||||
430 | 484 | 535 | 590 | 645 | 689 | 736 | 781 | 126 |
Other long-term liability | ||||||||
- | - | - | - | - | - | - | - | 500 |
Total liabilities | ||||||||
13,203 | 14,501 | 10,445 | 9,355 | 10,580 | 11,295 | 6,163 | 10,412 | 3,657 |
Commitments and contingencies (Note 11) | ||||||||
- | - | - | - | - | - | 0 | 0 | - |
Redeemable convertible preferred stock (Note 8) | ||||||||
- | - | - | - | - | - | - | - | 26,500 |
Stockholders’ equity: | ||||||||
Preferred stock, $0.0001 par value; 10,000,000 shares authorized and no shares issued or outstanding as of March 31, 2020 and December 31, 2019 | ||||||||
- | - | - | - | - | - | 0 | - | - |
Common stock, $0.0001 par value; 150,000,000 shares authorized as of March 31, 2020 and December 31, 2019; 36,031,166 and 31,673,058 shares issued as of March 31, 2020 and December 31, 2019, respectively; 36,010,998 and 31,642,806 shares outstanding as of March 31, 2020 and December 31, 2019, respectively | ||||||||
4 | 3 | 3 | 2 | 2 | 2 | 2 | 2 | - |
Additional paid-in capital | ||||||||
427,198 | 330,714 | 328,799 | 197,529 | 195,628 | 193,921 | 192,825 | 192,443 | 339 |
Accumulated deficit | ||||||||
-170,677 | -144,704 | -122,042 | -104,897 | -88,842 | -71,739 | -55,718 | -44,127 | -23,474 |
Total stockholders’ equity | ||||||||
256,525 | 186,013 | 206,760 | 92,634 | 106,788 | 122,184 | 137,109 | 148,318 | -23,135 |
Total liabilities and stockholders’ equity | ||||||||
269,728 | 200,514 | 217,205 | 101,989 | 117,368 | 133,479 | 143,272 | 158,730 | 7,022 |